<DOC>
	<DOCNO>NCT02718079</DOCNO>
	<brief_summary>The study conduct patient admit Department Hepatology Jan 2016 Jan 2018 Institute Liver &amp; Biliary Sciences , New Delhi . Study group comprise patient acute liver failure ( ALF ) option liver transplant ( due reason ) contraindication liver transplant prospective living donor assess enrollment trial .</brief_summary>
	<brief_title>High-Volume Plasma Exchange Versus Fractional Plasma Separation Adsorption ( Prometheus ) Patients With Acute Liver Failure</brief_title>
	<detailed_description />
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>Liver Failure , Acute</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Mannitol</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Patients acute liver failure define : Patients jaundice complicate encephalopathy coagulopathy within 4 week onset jaundice without underlie chronic liver disease . Age &lt; 12 &gt; 75 year HepatoCellular Carcinoma Active untreated Sepsis/DIC Any evidence active bleed secondary coagulopathy Hemodynamic instability require high dose Vasopressors Coma nonhepatic origin . Pregnancy Comorbidities associate poor outcome ( Extrahepatic neoplasia , severe cardiopulmonary disease define New York Heart Association score &gt; 3 , oxygen/steroiddependent chronic obstructive pulmonary disease ) . Patients take liver transplant Refusal participate study .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>